Updated results of the phase 3 AXIS trial: Axitinib vs sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Escudier, B.; Rini, B. I.; Hutson, T. E.; Gore, M.; Oudard, S.; Tarazi, J.; Rosbrook, B.; Williams, J. A.; Kim, S.; Motzer, R. J. |
| Abstract Title: | Updated results of the phase 3 AXIS trial: Axitinib vs sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 27th Annual Congress of the European Association of Urology |
| Journal Title: | European Urology, Supplements |
| Volume: | 11 |
| Issue: | 1 |
| Meeting Dates: | 2012 Feb 24-28 |
| Meeting Location: | Paris, France |
| ISSN: | 1569-9056 |
| Publisher: | European Association of Urology |
| Date Published: | 2012-02-01 |
| Start Page: | E81 |
| Language: | English |
| ACCESSION: | WOS:000303001300132 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 81 - "Source: Wos" |
MSK Authors
-
1243Motzer